ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery

In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capabilities, flexibility, reliability, and efficiency remains challenging due to the comp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chemical information and modeling 2024-08, Vol.64 (15), p.5900-5911
Hauptverfasser: Bou, Albert, Thomas, Morgan, Dittert, Sebastian, Navarro, Carles, Majewski, Maciej, Wang, Ye, Patel, Shivam, Tresadern, Gary, Ahmad, Mazen, Moens, Vincent, Sherman, Woody, Sciabola, Simone, De Fabritiis, Gianni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capabilities, flexibility, reliability, and efficiency remains challenging due to the complexity of advanced RL algorithms and the significant reliance on specialized code. In this work, we introduce ACEGEN, a comprehensive and streamlined toolkit tailored for generative drug design, built using TorchRL, a modern RL library that offers thoroughly tested reusable components. We validate ACEGEN by benchmarking against other published generative modeling algorithms and show comparable or improved performance. We also show examples of ACEGEN applied in multiple drug discovery case studies. ACEGEN is accessible at https://github.com/acellera/acegen-open and available for use under the MIT license.
ISSN:1549-9596
1549-960X
1549-960X
DOI:10.1021/acs.jcim.4c00895